World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

INNOVATION HIT RATE, PRODUCT ADVANTAGE, INNOVATIVENESS, AND FIRM PERFORMANCE

    https://doi.org/10.1142/S1363919614500388Cited by:1 (Source: Crossref)

    This study investigates the average levels of product advantage and innovativeness across the products in the firm's new product development (NPD) portfolio. Launch rate is defined as the percentage of products with a "launch" versus a "discontinued" outcome. A dataset of drug development activity for 73 pharmaceutical companies for the period 1995–2006 supports a positive relationship between average advantage and launch rate and between average innovativeness and launch rate. The interaction of high advantage and high innovativeness reduces launch rate. The distribution of activity across knowledge categories in the development portfolio strengthens the positive relationship between advantage and firm profitability.

    Remember to check out the Most Cited Articles!

    Be inspired by these New Titles in Business and Management